A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the efficacy and safety of HSK39004 InhalationSuspension in patients with moderate to severe Chronic Obstructive Pulmonary Disease(COPD).
Epistemonikos ID: f28784131e4734d8a47daa2f97948470d60c52ca
First added on: Jun 22, 2026